abstract |
The present invention relates to compositions and methods for cancer diagnosis, research and treatment, including but not limited to cancer markers. In particular, the present invention relates to ncRNAs as diagnostic markers and clinical targets for prostate, lung, breast, and pancreatic cancers. |